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The GroEL/GroES chaperonin folding chamber is an encapsulated space of 65 Å diameter with a
hydrophilic wall, inside of which many cellular proteins reach the native state. The question of
whether the cavity wall actively directs folding reactions or is playing a passive role has been open.
We review past and recent observations and conclude that the chamber functions as a passive
‘‘Anﬁnsen cage” that prevents folding monomers from multimolecular aggregation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Chaperonins are large oligomeric double ring assemblies that
carry out an essential function in the cell assisting many newly-
translated proteins to fold to their native forms [1–3]. The bacterial
chaperonin, GroEL, the most studied of this family, is a tetradeca-
mer of 57 kDa subunits, assembled as two back-to-back seven-
membered rings, each with a central cavity containing a hydropho-
bic lining to which a non-native polypeptide substrate can bind [4].
The co-chaperonin GroES, a seven-membered ring of 10 kDa sub-
units, associates as a ‘‘lid” structure with either end of GroEL in
an ATP-dependent manner to form an enclosed cavity with a
now hydrophilic wall character where folding of non-native sub-
strate proteins takes place [5–10] (see Fig. 1).
While the steps of the ATP-driven GroEL/GroES reaction cycle
have been generally understood for nearly 10 years, how this sys-
tem acts on substrate polypeptides to assist their proper folding
has remained unclear. It has been established, for example, that
non-native proteins are bound by an open ring, typically of an
asymmetric GroEL/GroES/ADP ‘‘bullet” complex ([11]; see Fig. 1,chemical Societies. Published by E
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wich).panels a and b], via hydrophobic contacts. Yet whether such bind-
ing mediates polypeptide unfolding, effectively taking a misfolded
protein back to the top of its energy landscape, has been unclear.
In the subsequent step of the reaction, GroES binding to the same
ring as polypeptide and ATP releases substrate from the cavity
wall into a now encapsulated hydrophilic chamber ([12–14];
Fig. 1c). The fate of substrate during this sequence of ATP-medi-
ated freeing of the apical domains, GroES collision, and large
forceful rigid body movements to produce the domed end-state,
has also been under study. Finally, protein folding proceeds with-
in the GroEL/GroES/ATP cis folding chamber, the longest-lived
state in the reaction cycle (Fig. 1c). Does the GroEL cavity wall ac-
tively direct or modify this reaction, or does it simply passively
contain the folding polypeptide? The ﬁrst questions, concerning
GroEL actions on polypeptide during the steps of polypeptide
binding and cis complex formation, are beginning to be resolved,
and we review current understanding of them at length else-
where. The present discussion focuses on the last question con-
cerning the mechanism by which the cis GroEL/GroES folding
chamber, a unique encapsulated hydrophilic cavity, supports pro-
ductive folding.
Our thesis, derived from recent experiments coupled with con-
sideration of past observations, is that the cis chamber is, as John
Ellis termed it in 1993, a passive ‘‘Anﬁnsen folding cage”, where
a non-native polypeptide chain is isolated as a monomer and em-
ploys the information intrinsic to its primary structure, in the ab-
sence of external information, to fold to its energetic minimum,
the native state [15]. The polypeptide may be subject to kinetic er-lsevier B.V. All rights reserved.
Fig. 1. Chaperonin reaction cycle. An asymmetric GroEL-GroES-ADP complex (a) is the normal acceptor state for ATP (red; also indicated as T) and non-native polypeptide
(green), binding them (b) in the open ring opposite the one bound by GroES (blue) and ADP (red D). ATP binding produces small rigid body apical domain movements in the
bound ring (b), enabling GroES binding, attended by large rigid body movements that produce the stable folding-active cis complex end-state (c). This folding-active state is
the longest-lived state of the reaction cycle, 10 s, followed by ATP hydrolysis (c? d), which then gates the entry of ATP and polypeptide into the opposite trans ring, rapidly
discharging the cis ligands (e) and initiating a new folding-active cycle on the ATP/polypeptide-bound ring.
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taking it off the productive pathway, but its conﬁnement as a
monomer protects it from multimolecular aggregation, enabling
kinetically unproductive monomeric states to ultimately redirect
themselves, through the energetic action of thermal ﬂuctuations,
onto a productive pathway to the native state. The major action
of the chamber is thus to prevent protein aggregation, which com-
prises, when reversible, a set of off-pathway diversions that slows
productive folding, and when irreversible, an off-pathway end-
state that diminishes yield and produces potentially harmful
structures.
In support of the foregoing conclusion about the cis chamber,
we summarize below a number of key observations concerning
the GroEL/GroES reaction. We focus ﬁrst on those derived from
studying the machine’s action under so-called non-permissive con-
ditions, where polypeptide substrate cannot reach the native state
without the presence of the complete GroEL/GroES/ATP system,
then on studies under permissive conditions, where the same pro-
tein substrates can reach the native state either while inside the
GroEL/GroES cavity or while folding free in solution.
2. Non-permissive conditions
2.1. Requirement for the GroES ‘‘lid”
The ﬁrst in vitro reconstitution of the chaperonin reaction
showed that both GroES and ATP had to be added to a binary com-
plex of GroEL and Rhodospirillum rubrum Rubisco in order to re-
cover native active Rubisco enzyme [16]. Notably that ﬁrst
experiment, and many that have followed, was carried out under
so-called non-permissive conditions, in particular involving a con-
centration of substrate protein (in that case 100 nM) and temper-
ature (25 C), where, in the absence of the GroEL/GroES system, the
substrate protein quantitatively aggregated, and where, for any
recovery of native protein, the complete chaperonin system was
required. In this latter regard, although GroEL alone at stoichiom-
etric or greater concentration could forestall aggregation, recovery
of the native state required GroES, whose binding to GroEL was
known to be ATP-dependent.
The role of GroES as an encapsulating agent was deduced from
EM and biochemical studies [5,6], and it was established that sub-
strate proteins as large as the R. rubrum Rubisco subunit (51 kDa)
could be refolded in the cis chamber formed when GroES bound
to GroEL [8,12]. One obvious well-commented role of this cham-
ber, which measures 65 Å in both height and diameter (Fig. 2),
was to provide a space where proteins of 20–60 kDa, the typicalsize of authentic cis substrates, could be conﬁned as single mole-
cules and would be unable to aggregate [10]. In addition, it
seemed unlikely that exposed hydrophobic surfaces of these
non-native states, surfaces that originally recruited them to the
hydrophobic lining of an open ring, would interact with the cis
cavity wall, because the wall of the cis chamber was observed
by X-ray studies to have been switched by rigid body movements,
which occur during ATP/GroES binding, to a polar character,
exposing 315 electrostatic side-chains and only 14 hydrophobic
ones [10,17].
3. Single round refolding mediated by SR1-GroES
The importance of the cis chamber to productive folding is high-
lighted by the observation that a single ring version of GroEL,
called SR1, which binds GroES in the presence of ATP but then does
not release it, is fully productive, with kinetics and extent of native
state recovery in this stable folding chamber that are virtually
identical to those of the cycling GroEL/GroES reaction, where GroES
and substrate polypeptide are discharged from GroEL approxi-
mately every 10 s [8,12]. The cis chamber of SR1/GroES is stable be-
cause the normal allosteric signal for discharge of the cis ligands,
ATP binding to the opposite (trans) GroEL ring, cannot occur – there
is no trans ring. Importantly, the length of time required for full
recovery of the native state of many substrate proteins, both by
the cycling reaction and by SR1/GroES, is greater than 15 min. In
the case of the SR1/GroES-mediated reaction, this implies that a
signiﬁcant fraction of the non-native states inside the cis chamber
of SR1/GroES can spend a relatively large amount of time exploring
their folding free energy landscapes without becoming irreversibly
trapped. They clearly do not have any requirement to be re-bound
by an open ring during this time, because they continue to form the
native state at the same rate as in a cycling reaction and ultimately,
as in the cycling reaction, they yield the native form with high efﬁ-
ciency, approaching 90–100% for many substrates.
Notably, there is just one round of ATP turnover by an SR1/
GroES complex, occurring in the ﬁrst 10 seconds after its forma-
tion, after which the complex is stable as an ADP-SR1/GroES com-
plex [6]. Thus there is no ongoing involvement of ATP in the folding
process inside this complex, and the polypeptide chain has to rely
on the energy of thermal ﬂuctuations to drive conformational
changes, essentially as it would if free in solution. The difference
is that, in this chamber, it cannot aggregate. It can remain unfolded
or misfolded as a monomer and thus is free of the complications of
an additional set of kinetic mis-steps involving multimolecular
associations.
Fig. 2. cis GroEL/GroES folding chamber. The domed chamber formed by GroES binding to a nucleotide-bound GroEL ring is shown in a cutaway view of a space-ﬁlling model,
with the wall character revealed by coloring of amino acid side-chains: red, acidic; blue, basic; yellow, hydrophobic; green, polar; white, main chain. Parts of three subunits
are visible. A number of residues are identiﬁed by the arrowing. Note that there is considerable electrostatic character to the wall (see text). eq., equatorial domain. Figure
adapted from Ref. [22].
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GroES be the same as in a cycling reaction, where a non-native
polypeptide spends time free in solution, subject to aggregation?
It appears that this is a function of the rapid rebinding of non-na-
tive forms during a cycling reaction, relative to the much longer
period of time these states spend folding inside the cis chamber
[8,18]. In studies employing mutant GroEL’s that function as poly-
peptide traps, it has been observed that non-native forms released
from a GroEL ring can be re-bound by another chaperonin mole-
cule in well under a second [19]. A more accurate estimate for
the rate of rebinding comes from kinetic measurements of ﬂuores-
cently labeled substrate binding. For example, the bimolecular rate
constant for MDH binding to GroEL has been measured as
2.4  106 M1 s1, enabling an estimate of the binding rate at a
physiologic GroEL concentration (1 lM) of 2.4 s1, which equates
to a half-time for binding of 0.3 s [18]. This can be compared to
the lifetime of a cis ternary folding complex of approximately
10 s [8,12,18]. Thus a non-native MDH polypeptide in a cycling
reaction spends no more than 3% of its time in free solution,
apparently insufﬁcient time to produce an effect on either the rate
or extent of recovery of the native state.
Do proteins in the cis cavity explore a conformational landscape,
as they would in free solution, or are they somehow behaving dif-
ferently? Studies using a secretory protein, bovine trypsinogen
(TG), to report on topology during folding indicate that conforma-
tions both on and off-pathway are being explored [20]. While TG is
normally folded in the ER compartment (absent a chaperonin sys-
tem), when it is diluted in vitro from denaturant and reductant intoa solution containing GroEL or SR1, it becomes efﬁciently bound to
the chaperonin, forestalling otherwise rapid and irreversible aggre-
gation. Upon addition of ATP, GroES, and a redox buffer (GSH/
GSSG), the protein proceeds to the native state with a half-time
of 45 min. The 12 cysteines of this protein, forming 6 disulﬁde
bonds in the native state, were used to report on three-dimen-
sional topology during folding by halting the reaction at various
times with alkylation and then recovering the TG to determine
by proteolysis and mass spectrometry what disulﬁde bonds had
been formed. At early times following initiation of folding, a collec-
tive of short-range disulﬁde bonds, both native and non-native,
were formed. Subsequently, three middle-range non-native bonds
as well as a long-range native bond were also detected. Both the
non-native and native bonds were detectable throughout the
course of the reaction, only resolving to all native at late times
when most of the molecules had reached native form. These data
imply that non-native off-pathway states do become populated
along with native ones during folding in the cis chamber. Whether
the non-native states are identical to the conformers that would be
formed in solution is not resolvable for this substrate, because it
has not been possible to refold TG in free solution. Even at 10
nM concentration and low temperature (what would be permissive
conditions for many proteins, see below), it quantitatively aggre-
gated upon dilution from denaturant on the timescale of a few sec-
onds (E.S. Park, unpublished observations). This latter behavior,
however, further reﬂects the beneﬁts of solitary conﬁnement in
the cis chamber as a means of preventing off-pathway multimolec-
ular associations.
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recovery of the native state
If the cis cavity prevents aggregation during a folding reaction,
then blocking return to the cavity following release into free solu-
tion should lead to a halt or diminution of further recovery of the
native state associated with the occurrence of aggregation, essen-
tially a repartitioning from monomeric chain folding in the cavity
to multimolecular aggregation in free solution. This was exactly
what was observed when, during a cycling reaction, polypeptide
substrate was blocked from returning to GroEL [21]. The study in-
volved engineering a programmable obstruction of an open sub-
strate-accepting GroEL ring by placement of an innocuous biotin
modiﬁcation at the cavity-facing aspect of the unliganded GroEL
ring. This enabled precipitous obstruction of the open cavity by
addition of streptavidin. During a folding reaction, such addition
produced a rapid halt to productive refolding of the substrates
Rubisco and rhodanese. For Rubisco, there was an immediate and
complete halt of recovery of activity upon prevention of its rebind-
ing, and the Rubisco present in free solution was reported to form
aggregates that were observable by centrifugation. Thus, released
non-native Rubisco conﬁned to free solution proceeded immedi-
ately to irreversible multimolecular aggregation. For rhodanese, a
small percentage of additional native protein was recovered over
a period of a fewminutes after addition of streptavidin. In this case,
a slower aggregation process apparently enabled a successful ki-
netic competition by a small fraction of the released monomers
for folding into the native state.
4. Role of the cis cavity wall in folding – mutational studies
If the GroEL cis cavity wall were actively inﬂuencing the refold-
ing of substrate proteins, it might be expected that amino acid sub-
stitutions affecting the wall would produce substantial effects on
rates of refolding or extent of recovery of the native state. While a
ﬁnal tally of suchmutations is not in as yet, it seems that, in general,
single substitutions are entirely benign and a number of multiple
mutations are likewise benign [22,23]. Although several multiple
mutants have shown effects in the overall reaction [23], the specif-
ics of the effects as they relate to the cis folding cavity have not been
fully evaluated, leaving open whether they are directly affecting cis
folding or some other aspect of the reaction cycle (e.g., substrate
binding or ATP hydrolysis).
4.1. No effects when hydrophilic residues are changed to hydrophobic
character
As noted above, it was observed with the ﬁrst X-ray structure of
a GroEL-GroES complex, the asymmetric GroEL–GroES–ADP7 com-
plex, that the cis cavity lining was hydrophilic in character, largely
devoid of hydrophobic side-chains ([10]; Fig. 2). This raised the is-
sue of whether mutations of hydrophilic cavity-facing residues
back to hydrophobic character could affect productive folding. A
variety of single, double, and triple substitutions changing acidic
or basic residues to valine or alanine were designed, and all were
without effect when tested in vivo by examining whether such
substituted GroEL’s could rescue a GroEL-deﬁcient strain; that is,
transformation with plasmids encoding the various substitutions
efﬁciently rescued cell growth [22].
4.2. Negative side-chains changed to polar but neutral character
An additional study measured effects of mutating acidic resi-
dues facing the cavity. In a cis cavity, there are 189 such nega-tively charged side-chains (27 per GroEL/GroES unit) and 126
positively charged side-chains (18 per unit) facing the cis cavity
(Fig. 2). Here, simultaneous mutation of three of the negative
side-chains to uncharged polar character (2 aspartates to aspara-
gine and 1 glutamate to glutamine: a loss of 21 total negative
charges per ring) was without effect; transformation of plasmids
encoding these substitutions produced efﬁcient rescue of cell
growth [23].
4.3. Reversal of charge, negative to positive
When the same residues were changed to lysine or when
three additional negatively charged residues were changed to un-
charged polar character, in both cases associated with a net loss
of 42 negative charges per ring, there was a strong reduction of
rescue efﬁciency [23]. Whether the growth defects of such mu-
tants, however, lie strictly at the level of the character of the
cis cavity wall, or lie instead at the level of polypeptide encapsu-
lation or ATP turnover, has not been addressed. The in vitro stud-
ies of these mutants to date have been limited to determination
of rates and extents of recovery inside the corresponding stable
mutant SR1/GroES complexes, revealing variable levels of recov-
ery of the native state depending on the substrate and mutant
examined [24]. Although these results were interpreted to indi-
cate a speciﬁc role of the cis cavity in directing the trajectory
or efﬁciency of folding, the effects of such substitutions on other
aspects of the chaperonin reaction were not evaluated. It remains
possible, however, that negatively charged residues have a role in
the cis cavity wall, potentially providing local repulsion to sub-
strates exposing negative charges during refolding. How or
whether a net negative charge of the wall, amounting to 20%
of the total of electrostatics, could have a general effect seems
unclear, albeit that there is a predominance of acidic proteins
in Escherichia coli. It seems possible that such charge contributes
to a ‘‘no stick” action of the cis cavity lining, which keeps col-
lapsed folding conformers from interacting with the cavity wall,
remanding them to their own primary structure for directing
the refolding reaction. On the other hand, this neglects the fact
that there are also basic proteins that are assisted by the chap-
eronin system; for example, mitochondrial malate dehydrogenase
(MDH; from pig heart), a commonly used GroEL/GroES substrate,
has a predicted isoelectric point of 8.2.
Indeed, any conclusion from studies employing six simulta-
neous substitutions per GroEL subunit (42 per ring) must also
be tempered by its reliance on investigation of a heavily mutag-
enized local region. Our experience with multiply substituted
GroEL’s has been that, while they may be able to assemble into
tetradecamers, they are often affected in multiple steps of the
reaction cycle, making attribution of observed defects to a single
step difﬁcult. This multiplicity of effects is in part a function of
residues playing different structural and functional roles in the
two major states. For example, rigid body movements of the ma-
chine bring a host of apical domain residues lying away from the
central cavity in an open binding-proﬁcient GroEL ring, where
they support the subunit-subunit interface, directly into the cis
cavity wall in the GroES-bound folding-active state. In addition,
within a single state, allosteric properties of the machine can
be at play, where, for example, a substitution in the apical do-
main can substantially affect the rate of ATP turnover in the
equatorial domain [25]. Finally, multiple local substitutions can
perturb local secondary structure, making it difﬁcult in the de-
scribed experiments to know whether there is simply a charge
effect as opposed to an additional effect, for example, on local
structure of the cavity.
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folding does not affect the GroEL cavity wall but combines
ATPase stimulating mutations of GroEL with alteration of a
cavity-facing GroES residue
Using the observation that the aggregation-prone behavior of
GFP expressed in E. coli can be countered to some extent by over-
expression of GroEL/GroES, increasing the recovery of green ﬂuo-
rescence, a mutagenesis was carried out on GroEL/GroES aimed
at further optimizing the efﬁciency of GFP folding and recovery
of ﬂuorescence [26]. Strikingly, none of the mutations improving
ﬂuorescence mapped to the GroEL cavity lining. Instead, combina-
tions of mutations were obtained, simultaneously affecting both
GroEL and GroES. The mutations affecting GroEL mapped to the
equatorial and intermediate domains and, when studied in vitro,
all of them accelerated the GroEL ATPase (and enhanced the sup-
pression of ATPase activity by GroES). The effective mutations in
GroES mapped to a single site, tyrosine 71, whose side chain pro-
jects into the cavity at its top aspect (Fig. 2), the collective of seven
forming a hydrophobic ridge in what is otherwise a hydrophilic,
net negatively charged portion of the cis cavity contributed by
GroES. Here the residue was changed to either arginine or histi-
dine. At ﬁrst glance, it would seem that the GroES substitutions
might be acting by changing the lining contiguous to refolding
GFP, inﬂuencing the kinetics of its cis folding, but, when examined
alone in vivo, only a small effect of the GroES substitutions to im-
prove GFP ﬂuorescence was observed (increase of 50–100%). In-
stead, the major effect (increase of 500–600%) was contributed
by the GroEL substitutions, affecting the ATPase. Given the obser-
vations of Horovitz and coworkers that mutations in GroES can
strongly affect the GroEL ATPase [27], an effect on ATPase activity
by the Y71 changes remains an alternative possibility to the con-
clusion that local effects on cavity character had improved recov-
ery of ﬂuorescent GFP. Given the altered ATPase behavior of the
substituted GroEL’s in the presence of wild-type GroES, it is attrac-
tive to consider that the Tyr71 substitutions may be further mod-
ulating such behavior. Notably, while the ATPase activity of the
substituted GroEL’s was reported, the effects on ATPase activity
of the substituted GroES’s were not presented. Signiﬁcantly, the
improvement of GFP folding, presumably largely through adjust-
ment of the ATPase cycle timing, came at the price of reduced fold-
ing of other substrate proteins, as indicated by loss of growth at
heat shock temperature, inability to support k phage growth, and
reduced ability to fold a substrate, HrcA. Finally, the action of the
various substitutions on GFP folding could not be fully resolved be-
cause the substituted chaperonins produced little or no effect on
the rate or extent of GFP refolding in vitro, leaving uncertain
whether the effects observed in vivo were related at all to the func-
tion of the cis cavity as a folding chamber.5.1. Summary concerning effects of mutations in the cavity wall
In summary concerning mutations of the cis cavity wall, it has
to be concluded that single substitutions (7 per ring) in general
do not have the profound effects on the step of productive sub-
strate folding in the cavity that a host of single cavity-facing sub-
stitutions had on the step of substrate polypeptide binding by
the open GroEL ring. In that case, changes of any one of ten individ-
ual cavity-facing hydrophobic residues to hydrophilic character (7
per ring) abolished polypeptide binding and completely abolished
rescue of growth of a GroEL-deﬁcient strain in vivo [28]. In the case
of the cis cavity electrostatic studies, two triple mutations were
without effect, and while both a third mutation carrying out triple
charge reversal and a sextuple negative charge-to-polar mutant ex-
erted a variable effect on folding in vitro, there was still a degree ofrescue in vivo. Thus, it seems difﬁcult to interpret such results as
evidence that the cavity wall is actively directing the folding reac-
tion, as opposed to simply comprising a hydrophilic ‘‘non-stick”
surface. That is, it seems more likely that overall wall character is
involved here, as a non-stick barrier, as opposed to providing direct
interactions between individual wall residues and speciﬁc residues
of a folding polypeptide chain. It appears that evolution has opti-
mized a non-stick wall for the folding chamber, not speciﬁc sets
of interactions between the wall and each of dozens of refolding
substrate proteins. Consider at the extreme the cross-kingdom-
mediated folding by bacterial GroEL of proteins from eukaryotic
mitochondria – there is a very large evolutionary separation in-
volved, yet folding in the cis cavity proceeds efﬁciently. The lack
of residue-speciﬁc interactions is further supported by additional
experimental data reviewed below that conclude that the ‘‘intrin-
sic” rates of reaching the native state inside the cavity and outside
in solution are the same if one removes the complication of multi-
molecular aggregation occurring in solution. This enforces the no-
tion that the cavity wall has evolved to be inert relative to
monomeric chain folding.6. Folding to native form under permissive conditions in the cis
cavity vs free in solution – the rate is the same but folding free
in solution is kinetically complicated by reversible
multimolecular aggregation
Early after their reconstitution of GroEL/GroES-mediated refold-
ing of R. rubrum Rubisco, the Lorimer group observed that, if the
temperature of the refolding reaction was lowered from 25 C to
15 C or below, Rubisco could now spontaneously and quantita-
tively refold to its native form in solution [29]. While there was a
virtually complete recovery of the native state, the rate of recovery
was only approximately one tenth that of the GroEL/GroES/ATP
reaction carried out under the same conditions. The authors com-
mented concerning this difference: ‘‘Presumably, intermolecular
aggregation is suppressed at lower temperatures, enabling proper
intramolecular folding reactions to predominate . . .At higher tem-
peratures, restrictive for spontaneous folding, the formation of
aggregates is largely avoided by a stable interaction. . .with
the. . .‘double donut’ [GroEL]. . .We propose that cpn60 is the bio-
logical equivalent of. . .insoluble matrices, permitting unfolded
polypeptides to undergo folding rather than aggregation”. At that
point in history, both this study and another [30] could only spec-
ulate that cpn10 (GroES) functioned as a ‘‘coupling factor”,
although this anticipated the understanding that GroES functions
as a physically encapsulating ‘‘lid”. Clearly spelled out, however,
was the notion that permissive conditions simply shifted kinetic
partitioning of the non-native monomer in solution frommultimo-
lecular aggregation toward productive folding. Likewise clear was
the proposal that acceleration of folding by the GroEL/GroES sys-
tem under these conditions represented an even more extensive
partitioning away from aggregation.
A more recent study likewise observed the acceleration of Rubi-
sco folding by the GroEL/GroES system under permissive condi-
tions, but it concluded that this represented not an effect on
multimolecular association but rather the elimination of off-path-
way misfolding of Rubisco monomer under these conditions by
‘‘close conﬁnement” in the cis cavity [21]. This conveys the idea
that such conﬁnement of a relatively large substrate would entro-
pically favor more collapsed states, potentially favoring formation
of the native state. Such an idea further implies that the cis cavity is
playing an active role in folding this substrate. Notably, however,
this study of Rubisco refolding, like the earlier study from the Lori-
mer group, added 1 mg/ml bovine serum albumin (BSA) to the
reaction mixtures. One would assume that such an addition was,
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tion that favored folding over aggregation or prevented its loss on
the tube walls. This leaves open to consideration whether the solu-
tion reaction might contain Rubisco species that were other than
monomeric and that contributed to the difference in folding
kinetics.
To directly address the behavior of Rubisco under these condi-
tions, Adrian Apetri of our laboratory has recently carried out a
number of tests [31]. First, he examined the effect of omission of
BSA on recovery of Rubisco under permissive refolding conditions
either free in solution or in the GroEL/GroES reaction. Strikingly, he
observed in the case of the solution reaction that, upon omission of
BSA, there was essentially no recovery of native Rubisco. By con-
trast, the rapid rate of refolding by the GroEL/GroES system re-
mained unchanged in the absence of BSA. Second, he assessed
whether Rubisco aggregation could occur while free in solution
even in the presence of BSA, using both dynamic light scattering
and gel ﬁltration chromatography, observing by both analyses that
aggregation indeed occurred. In the ﬁrst test, light scattering in-
creased rapidly following dilution of Rubisco from denaturant into
the BSA-containing buffer used for refolding under permissive con-
ditions (observable at the earliest time of measurement after mix-
ing, within seconds). In gel ﬁltration using radiolabeled Rubisco,
the formation of a collective of Rubisco species of several hundred
kDa was observed within minutes of dilution into refolding buffer.
By contrast, no Rubisco monomer was observed. At 75 and 140 min
(75 min corresponding to t½ for refolding), the species of several
hundred kDa were no longer observed, converted approximately
equally into 100 kDa native dimeric protein and into larger aggre-
gates at the void volume of the gel ﬁltration column (10 MDa).
Thus, a very substantial fraction of the Rubisco that forms aggre-
gates at early times is able to convert into the native state, presum-
ably because the aggregation is reversible. This offers a probable
explanation for the relatively slow rate of refolding of Rubisco free
in solution under permissive conditions; as conjectured in the
1990 paper from the Lorimer group [29], the protein is reversibly
aggregating.
A further GroEL/GroES dependent substrate whose rate of fold-
ing under permissive conditions is 10-fold faster at GroEL/GroES
than in free solution, a double mutant form of maltose-binding
protein (DM-MBP) [32], has also been examined and proposed as
a further example of a protein whose folding is actively affected
by the cis cavity [24]. Here also, however, as opposed to an effect
of the cis cavity to accelerate folding of the monomeric species, it
appears that it is reversible multimolecular aggregation in solution
that is leading to slowing of the rate of reaching the native state in
that setting. For example, the rate of folding of the double mutant
protein when free in solution was inversely dependent on concen-
tration, a tell-tale sign of protein aggregation [31]. Further, DM-
MBP diluted from denaturant exhibited light scattering whereas
wild-type MBP protein did not. Finally, if chloride ions were omit-
ted from the refolding buffer, light scattering during folding in
solution did not occur. If aggregation was the source of slowed
folding relative to the GroEL/GroES reaction, then chloride omis-
sion should also restore the rate of refolding in solution to that in-
side the chaperonin. This was indeed observed, with the curves of
recovery now being indistinguishable between folding free in solu-
tion and chaperonin-assisted [31]. This further establishes that it is
reversible aggregation under permissive conditions during folding
in solution that contributes (entirely, as observed here) to the
slower rates of folding in this setting than inside the cis cavity. This
leaves the hypothesis of an active role in folding for the cis cham-
ber unsupported.
Finally, Apetri addressed a further experiment toward the func-
tion of the cis chamber, asking whether it could have any active
role in protecting an already native protein against the conse-quences of misfolding, here induced by thermal exposure, a condi-
tion known to produce protein misfolding and aggregation [31].
Human dihydrofolate reductase (DHFR), refolded to its native state
either free in solution or inside the chamber of SR1/GroES formed
in ADP-AlFx (a transition state analogue of ATP that further stabi-
lizes the complex against dissociation), was exposed to various ele-
vated temperatures for a period of 10 min, followed by immediate
assay at 23 C, asking whether there was any difference in protein
inactivation between the two conditions. None was observed, sug-
gesting no particular ability of the cis cavity to protect DHFR
against thermal inactivation. In the case of 50 C exposure, the
DHFR was completely inactivated. This reaction mixture was
downshifted to 23 C for a half hour and then assayed for recovery
of DHFR enzyme activity. Whereas the solution reaction failed to
exhibit any recovery, having already formed noticeable aggregates
observable by light scattering during the thermal treatment, the
SR1/GroES mixture exhibited a recovery of 50% of the input DHFR
in active form. The cis chamber had thus apparently protected the
thermally misfolded protein from aggregation and had allowed a
substantial fraction of the encapsulated monomers to recover the
native state. This thus comprises a further demonstration that
the cis cavity acts to protect monomeric species against
aggregation.7. Folding trajectories inside the cis cavity and in solution
If productive non-aggregated monomers folding inside the
chaperonin and free in solution under permissive conditions lie
on the same energy landscape, then one would predict that probes
of the trajectory of such folding should show identical time-depen-
dent changes. Such an experiment was carried out using human
DHFR as substrate, analyzing its development of amide proton pro-
tection during refolding, either inside the SR1/GroES cavity or free
in solution, by hydrogen–deuterium exchange and nuclear mag-
netic resonance (NMR) [33]. The experiment was carried out under
permissive conditions at 15 C, where the rates of recovery of na-
tive DHFR inside the cis cavity and free in solution were roughly
equal, but where the extent of recovery in solution was reduced
to 50% due to formation of aggregates. The equal rates of native
state recovery imply that here, in contrast to DM-MBP, there is
no signiﬁcant reversible aggregation in free solution – aggregated
DHFR appears to be irrecoverable. As such, however, the aggre-
gated material could be readily removed from the solution reaction
by centrifugation, allowing direct comparison of the DHFR folding
free in solution with the cis encapsulated DHFR. Refolding was
commenced in protic solution by dilution of DHFR from urea dena-
turant or by addition of ATP/GroES to a SR1-DHFR binary complex,
and then, at various times during the reaction, a 10-fold volume
excess of D2O was added and the folding reaction simply allowed
to proceed to completion in D2O. Native DHFR recovered from
either reaction was analyzed by NMR spectroscopy for the relative
intensity of 51 amide ‘‘probes”, which are from non-surface resi-
dues highly protected in the native state. When an amide proton
had become incorporated into a hydrogen bond by the time of
addition of D2O, it would remain protected against exchange and
be NMR visible in analysis of the native protein. When it was not
bonded at the time of exchange (or not buried), it would be ex-
changed for a deuteron and would become NMR invisible. In this
way, both the development of protection and the location of pro-
tection in DHFR in the two settings could be compared. These com-
parisons revealed an identical trajectory and pattern of protection
in DHFR when folding either free in solution or conﬁned to the cis
cavity. In both cases, there was early protection (15 s) observed in
the central parallel b-sheet of the protein, followed by progressive
development of protection in surrounding regions including the a-
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developing under both conditions (unpublished observations; see
also discussion of the initial states from which folding commences
in the last section below). Thus the same route to the native state
appears to be taken by DHFR monomers in both settings and, like-
wise, the same kinetics are followed. Strikingly, of course, in free
solution the reaction was signiﬁcantly less efﬁcient, complicated
by production of irreversible aggregates. These data further rein-
force the idea that the cis cavity of the chaperonin does not inﬂu-
ence or otherwise direct the folding of a substrate polypeptide.
8. Further considerations regarding behavior of the cis cavity
toward particular substrate proteins
A number of additional experimental ﬁndings are worth consid-
ering in relation to the apparently passive behavior of the GroEL/
GroES cis cavity as a device for preventing aggregation during fold-
ing. These concern its behavior toward a number of speciﬁc
substrates.
8.1. Actin and tubulin
Unfolded forms of these two eukaryotic cytoskeletal proteins
are efﬁciently bound by GroEL upon dilution from denaturant,
but upon addition of ATP/GroES, they are fated to continuous cy-
cling by the system without ever reaching native form [34]. Clearly
the cis cavity prevents aggregation in this non-permissive context,
because if these same substrates are diluted into free solution they
quantitatively aggregate. Why they fail to reach native form re-
mains unclear. By contrast, the dedicated eukaryotic cytosolic
chaperonin, CCT, efﬁciently binds and refolds these same proteins
[35,36], but, in contrast, does not recognize such GroEL substrate
proteins as MDH or rhodanese. Thus, the CCT chaperonin, in con-
trast with GroEL, may recognize features other than hydrophobic-
ity of non-native states, or may recognize hydrophobicity only in a
speciﬁc structural context [see Ref. [3] for discussion]. In this re-
gard, later-formed conformations than those bound by GroEL
may be recognized by CCT. Alternatively, the nature of ATP-medi-
ated release of bound substrate by CCT may be different from that
of GroEL, with sequential release occurring from the heterologous
subunits [37] as opposed to the concerted release directed by ATP/
GroES from the GroEL cavity wall. Sequential release of a character-
istically bound substrate could produce a process of folding that is
directly ordered by the chaperonin. Potentially, this could be cru-
cial to steps of actin and tubulin folding that will always kinetically
‘‘go wrong” in the case of concerted release into the GroEL/GroES
cis chamber. Such considerations are, however, in the absence of
any experimental data, purely speculative.8.2. T4 gp23
The T4 phage major capsid protein, product of gene 23, was
known by 1970 to be the single dominant protein species produced
in T4 phage-infected E. coli, and its assembly into phage particles
was noticed to require action of the phage’s gene 31 protein,
gp31. It was then observed by Georgopoulos and colleagues in
1972 that E. coli strains harboring mutations in the host gene
encoding GroEL were also not able to produce phage particles, with
the phage capsid protein observed in aggregates, termed ‘‘lumps”,
associated with the bacterial membrane [38]. Twenty years then
elapsed before genetic and biochemical studies by Georgopoulos
and coworkers made clear that gp31 is in fact a phage-encoded
version of GroES, supporting phage growth in vivo and forming a
7-membered homooligomeric ring that in vitro can both physically
associate with GroEL in the presence of ATP and mediate folding ofseveral well-studied GroEL substrate proteins [39]. X-ray studies of
gp31 then indicated that its ring structure exhibited a taller inside
cavity height than GroES [40], and consistently, it was recognized
in in vitro studies that, whereas GroES could not encapsulate
GroEL-bound capsid protein, the gp31 component was able to do
so, thus allowing for cis folding of the capsid protein [41]. Very re-
cently, the refolded capsid protein enclosed inside a stable GroEL-
gp31-ADP/AlFx cage has been resolved as a density inside the cis
chamber, using cryoEM [42]. The capsid protein extensively ﬁlls
the cis chamber and appears to occupy a speciﬁc orientation inside
of it. But most remarkable in functional terms, however, is the
observation from Georgopoulos and coworkers that phage-
encoded gp31 can completely replace GroES in E. coli to support
the essential function of GroES, conferring normal cell growth
[43]. This indicates that gp31 can support the productive refolding
of all of the natural GroEL-GroES-dependent substrates of the bac-
terial cell. These substrate proteins have never ‘‘seen” T4 gp31, nor
ever had to rely on it for productive refolding. This further implies
a passive role, here for the co-chaperonin lid structure, in cis cham-
ber folding.
8.3. Implications of prolonged rotational correlation times of substrate
proteins inside the cis cavity relative to free solution
Early measurements of time-resolved ﬂuorescence anisotropy
performed with native GFP either inside GroEL/GroES or free in
solution suggested that the protein tumbles several times more
slowly inside the cis chamber than free in solution [8]. This is not
surprising considering that the protein is encapsulated, and as
such, must be affected in its rotational and translational move-
ments by collisions with the cavity wall. Yet the measured rota-
tional correlation time, 42 ns, is considerably faster than that of
GroEL itself under similar conditions, which is >200 ns as mea-
sured by NMR studies [44]. This implies that the substrate has con-
siderable freedom within the cis chamber, presumably sufﬁcient to
allow the conformational changes of chain folding of substrate
polypeptide to proceed without impairment by collisions with
the cavity wall.
8.4. Difference of initial collapse of non-native forms released from
cavity wall vs diluted from denaturant
It seems likely that the ensemble of conformations present
immediately after the initial step of collapse of a chaotrope-un-
folded polypeptide upon dilution into aqueous buffer, effectively
collapse of a random coil, would be different from that produced
by the step of release of an already-collapsed globular substrate
from the cavity wall of a GroEL ring. This latter step appears to in-
volve a concerted release of the bound polypeptide chain from the
apical domains into the cis chamber [45,46], although it has been
suggested from a recent ﬂuorescence study that hydrophobic seg-
ments may be last to leave the apical domains [14]. Yet beyond the
step of initial collapse either in solution or in the cis cavity, which
must occur in well under 1 second, it appears that the same
ensembles of collapsed non-native states are likely to be popu-
lated. This would explain, for example, the virtually identical re-
sults from analysis of amide hydrogen–deuterium exchange
protection of DHFR folding in cis vs free solution [33].
There remains, however, an observation that refolding of GFP in
the two environments shows some difference, with refolding in the
complete chaperonin reaction, measured by acquisition of ﬂuores-
cence, exhibiting a lag of 3 s, relative to immediate appearance of
ﬂuorescence when refolding either free in solution after dilution
from denaturant or upon addition of ATP alone to a GroEL/GFP bin-
ary complex ([47]; GFP generally refolds permissively). It thus ap-
pears that GroES binding is associated with the lag in recovery,
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transiently kinetically trapped in the states formed after release
into the cis chamber. Perhaps an early state with an extended
geometry that is a direct route to the native state cannot be formed
in the conﬁnes of the cis cavity. Alternatively, concerted release of
the protein, associated with the large apical movements upon ATP
and GroES binding, may beget a particular state that is trapped. By
contrast, the smaller apical movements produced by ATP binding
alone [48] may not produce such a state. Whatever the case for
GFP, its behavior appears exceptional. By contrast, such other sub-
strates as MDH ([17], see Suppl. Fig. 1) and MBP (A. Apetri, unpub-
lished observations) exhibit single exponential recovery of the
native state, devoid of any such lag phase, indicating that for those
substrates productive folding in the cis chamber commences
immediately upon release.
9. Concluding remarks
In sum, then, the experiments and their interpretations pre-
sented here all support the conclusion that the GroEL/GroES cavity
is indeed a passive ‘‘Anﬁnsen folding cage,” as suggested by Ellis.
The hydrophilic, net negatively charged, lining of the cavity pro-
vides a non-stick surface that effectively forces a non-native poly-
peptide to follow its intrinsic folding pathways without providing
any general or substrate-speciﬁc direction to the process. The
observation of identical folding trajectories within the cavity and
free in solution conﬁrms that GroEL/GroES-mediated folding con-
forms to Anﬁnsen’s principles. Furthermore, it seems clear that
the chaperonin’s anti-aggregation actions, both in binding non-na-
tive polypeptides and in permitting them to fold in a sequestered
environment, are crucial to its essential roles both in folding new-
ly-translated proteins and in protection and recovery of cells from
heat shock. The generality of such actions is what allows the chap-
eronin system to efﬁciently assist its wide range of protein sub-
strates to reach their native, functional state.
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